CDRR'S QPIRA Training Workshop On Drug Registration: Eliza G. Sison
CDRR'S QPIRA Training Workshop On Drug Registration: Eliza G. Sison
Department of Health
Food and Drug Administration
Powerpoint by:
Eliza G. Sison
Food-Drug Regulation Officer III
Presented by:
Kyla G. Catolico
Pharmacist II
Center for Drug Regulation and Research
1
08 May 2014
Republic of the Philippines
Department of Health
Food and Drug Administration
PART I
ADMINISTRATIVE AND
PRESCRIBING INFORMATION
2
Coverage
• Application Form
• Letter of Authorization
• Certifications
3
Application Form (1)
• Letter of application
– Bureau Circular No. 01 s. 2002
Annex A for NCE and Generic
Applications
› Notarized, duly signed and dated by the
responsible person(s)
4
Application Form (2)
5
Application Form (3)
– Administrative Order 2005-0001
A CPR issued may be cancelled and/or
revoked should the Intellectual Property
Office (IPO) or court of law of
competent jurisdiction decide with
finality that the applicant has no
intellectual property right over a
pharmaceutical product.
FDA shall be held free and harmless
against any and all third-party claims
arising from the registration of a
pharmaceutical product. 6
Application Form (4)
• Administrative Order No. 2005-0016
–The submitted brand name shall be
changed should the proper authority
decide with finality that the applicant has
no right to utilize the said brand name.
–FDA shall be held free and harmless
against any and all third-party claims
arising from the acceptance of the said
product intended for registration with
FDA.
7
Application Form (5)
• Details of the Active Pharmaceutical
Ingredient (API):
–Duly accomplished
–Information shall be consistent with that
declared on the Letter of Application and
other documents provided.
9
Letter of authorization (1)
Letterhead of Applicant Company
Heading “ Letter of
Authorization”
Product owner’s name and address
Applicant’s name and address
Registration application
Product Name
Signature: ______________
Date: ______________ 11
Letter of authorization (3)
MODEL OF LETTER OF AUTHORISATION
Company’s Letterhead
LETTER OF AUTHORIZATION
We,
______________________________________________________________
Product Owner’s Name and Address
Hereby appoint
__________________________________________________________
Applicant’s Name and Address
To apply for registration of our pharmaceutical product
Product Name ____________________
Dosage Form and Strength ____________________
With the Drug Regulatory Authority in (state country) on our behalf . They
will be the marketing authorization holder of the registration certificate and
be responsible for all matters pertaining to the regulation of this product.
Signature : __________________
Date : 12
Certifications (1)
SCOPE
• For contract manufacturing:
a. License of pharmaceutical industries
and contract manufacturer
b. Contract manufacturing agreement
c. GMP certificate of contract
manufacturer
13
Certifications (2)
15
Certifications (4)
• For imported products:
a. License of pharmaceutical
industries/importer/wholesaler (country
specific)
b. Certificate of Pharmaceutical Product
issued by the competent authority in the
country of origin according to the current
WHO format (Appendix III)
c. Site master file of manufacturer (unless
previously submitted within the last 2
years) (country specific )
16
Certifications (5)
• Specific requirements
• License of pharmaceutical industries/License-
to-Operate (1)
• For a Drug Manufacturer (including Packer and
Repacker)
• Valid or with proof of renewal
• Shall state the capability to produce the specific
product line/class and dosage form
• Shall declare the name of the drug trader with
toll/contract manufacturing arrangement with
the manufacturer (if applicable)
17
Certifications (6)
• License of pharmaceutical
industries/License-to-Operate (2)
• For a Drug Trader
• Valid or with proof of renewal
• Shall declare the name of the toll/contract
manufacturer and information on the
product to be registered (generic name and
dosage form will usually suffice)
18
Certifications (7)
• License of pharmaceutical
industries/License-to-Operate (3)
• For a Drug Distributor/Importer/Wholesaler
• Valid or with proof of renewal
• Shall declare the corresponding source of
the product including the company name
and business address
19
Certifications (8)
• Contract of manufacturing agreement (1)
• a local manufacturer and a trader
• a local manufacturer and its designated
distributor/wholesaler
• a foreign manufacturer and a distributor/
importer
• a foreign product license holder and a
distributor/importer
• a distributor/importer and its designated
distributor/wholesaler
20
Certifications (9)
• Contract of manufacturing agreement (2)
• Valid/Have not yet expired
• Duly signed by the responsible person(s) of
the parties involved
• Includes the list of products covered in the
agreement
• Declares the specific activities that each
party shall undertake
21
Certifications (10)
• Certificate of Pharmaceutical Product (1)
For imported products
In original copy and written/translated in
English
Valid/Have not expired
An open-ended certificate is deemed
expired one year after its issuance
22
Certifications (11)
• Certificate of Pharmaceutical Product (2)
Conforms to the format recommended by WHO
(as per certification scheme on the quality of
pharmaceutical products moving in international
commerce)
Shall include the following information:
The Philippines as the importing/requesting
country
23
Certifications (12)
• Certificate of Pharmaceutical Product (3)
Complete quantitative composition of the
product
Statement that the product is both
registered and freely sold in the country
of origin
24
Certifications (13)
• Certificate of Pharmaceutical Product (4)
Statement that the production facilities
conform to Good Manufacturing Practice
(GMP)
the importing/requesting country
25
Certifications (14)
• Certificate of Pharmaceutical Product (5)
http://www.who.int/medicines/areas/quality_safety/
regulation_legislation/certification/en/
Guidelines on the implementation of the WHO
certification scheme
Contact list of competent authorities of
countries participating in the WHO certification
scheme
26
Certifications (15)
• Certificates of Free Sale and GMP (1)
– For countries not participating in the WHO
certification scheme, the following shall be
submitted:
I. Certificate of Free Sale from the country
of origin
Written/Translated in English, and duly
authenticated by the territorial Philippine
Consulate
27
Certifications (16)
• Certificates of Free Sale and GMP (2)
Shall contain the generic name or
international non-proprietary name (INN)
of the active ingredient(s), brand name (if
any), dosage strength and form, and the
complete name and address of the
manufacturer and any other entities which
claim responsibility for the product
28
Certifications (17)
• Certificates of Free Sale and GMP (3)
II. Government certificate attesting to
the registration status of the
manufacturer
Written/Translated in English, and
duly authenticated by the territorial
Philippine Consulate
29
Certifications (18)
• Certificates of Free Sale and GMP (4)
Shall state the capability to
manufacture the specific product
line/class and dosage form, and that
the production facilities conform to
GMP.
30
Certifications (19)
• Certificates of Free Sale and GMP (5)
In case the product is registered but not freely
sold in the country of origin, either one of the
following may be submitted:
I. Original copy of CoPP from another
country with a competent DRA, and
where the product is both registered and
freely sold;
31
Certifications (20)
• Certificates of Free Sale and GMP (6)
II. CFS duly authenticated by the
territorial Philippine Consulate from
another country with a competent
DRA and where the product is both
registered and freely sold; or
32
Certifications (21)
• Certificates of Free Sale and GMP (7)
III. [If the product is not registered in
any other country other than the
country of origin] Export Certificate
duly authenticated by the territorial
Philippine Consulate from the
country of origin.
33
Certifications (22)
• Site master file of manufacturer
– Administrative Order no. 2012-0008
Adoption and Implementation of the
Pharmaceutical Inspection Cooperation
Scheme (PIC/S) Guides for the Good
Manufacturing Practice (GMP) for
Medicinal Products
http://www.picscheme.org/publication.phpPE 008-
4 Guideline for PharmaceuticalManufacturers on
the preparation of a site master file
34
Republic of the Philippines
Department of Health
Food and Drug Administration
Thank You!
35